Recommended Vaccinations under National Adult Immunisation Schedule
From 1 November 2020, Singaporean adults will benefit from subsidies1 for recommended vaccinations under the National Adult Immunisation Programme (NAIS), and can use their MediSave for co-payment of these vaccinations.
Prior to taking the vaccination, please consult with our doctor to find out which vaccinations are recommended, and if you are suitable for the vaccination(s).
Eligibility criteria for subsidies apply. MediSave eligibility criteria and limits apply. Recommended vaccinations differ for different target population groups. Terms and conditions apply.
1Source: MOH
Summary of National Adult Immunisation Schedule1
| Vaccines | Recommended Groups | Schedule |
|---|---|---|
| Influenza |
| 1 dose annually |
| Pneumococcal (Included under NAIS: 13-valent pneumococcal conjugate vaccine (PCV13) and 23-valent pneumococcal polysaccharide vaccine (PPSV23) |
| 1 dose each of 2 vaccines |
| Pneumococcal (Included under NAIS: 13-valent pneumococcal conjugate vaccine (PCV13) and 23-valent pneumococcal polysaccharide vaccine (PPSV23) |
| 1 or 2 doses |
| Pneumococcal 20-Valent Pneumococcal Conjugate Vaccine (PCV20) |
| 1 doses Effective from 1 September 2025 |
| Human Papillomavirus (HPV) Included under NAIS: Bivalent HPV vaccine (HPV2) |
| 3 doses (0, 1 – 2, 6 months) |
| Tetanus, Diphtheria and Pertussis (Tdap) |
| 1 dose per pregnancy (16 – 32 weeks) |
| Measles, Mumps and Rubella (MMR) |
| 2 doses |
| Hepatitis B |
| 3 doses |
| Varicella |
| 2 doses |
| Shingles Recombinant Herpes Zoster Vaccine (RHZV) |
| 2 doses (2 – 6 months) Effective from 1 September 2025 |
Source: MOH
FAQ
#Patients can utilise their own, or their immediate family member’s MediSave.
Different MediSave limits and eligibility criteria apply for different healthcare programmes.
1 MOH official press release
2 CPF ​Scheme - Medisave information